跳至主要内容
临床试验/NCT06074861
NCT06074861已完成不适用

The Effect of a Fast-mimicking Diet on Periodontal Clinical and Systemic Response to Non-surgical Treatment of Stage III-IV Periodontitis: a Multi-centre Randomised Controlled Trial With Internal Pilot

Universitat Internacional de Catalunya5 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2023年12月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
5
主要终点
High-sensitivity C-reactive protein (hs-CRP) values in serum

研究概览

简要总结

Periodontitis (gum disease) leads to the formation of gum pockets. Its treatment involves deep cleaning of the teeth, to remove soft and hard tooth deposits under the gum line. Although in the long term this leads to improvement of the gum conditions and reduced inflammation, in the hours and days post-treatment, inflammation may increase, sometimes also associated with a high temperature. A method to reduce this response has not been found yet.

The goal of this multi-centre randomized controlled trial is to to test if a diet which acts to mimic periodic fasting can influence responses in the mouth and throughout the body after treatment of gum disease in patients with advanced gum disease but general health conditions. Five Spanish centres (Universidad Complutense de Madrid, Universidad Internacional de Catalunya, Universidad de Murcia, Universidad de Santiago de Compostela, Universidad de Granada) will perform the clinical part of the study, whereas the King's College of London (Guy's Hospital) will provide the analyses and processing of the data. Researchers will include 28 patients in total.

The main question it aims to answer is:

- Is a mimic periodic fasting (together with the classical gum treatment) effective at reducing the local and systemic inflammation provoked by the gum disease (and by the same treatment) in the short- and medium term?

Although all participants will receive the necessary gum treatment (deep cleaning), researchers will randomly assign them to one of two groups.

The test group will follow three cycles (the same day of the treatment, and 45- and 85 days after treatment) of 5 days each of a fasting-mimicking diet (FMD). The FMD program is a plant-based diet program designed to attain fasting-like effects while providing both macro- and micronutrients to minimize the burden of fasting and adverse effects. The FMD consists of 100% ingredients that are generally regarded as safe (GRAS) and comprises proprietary vegetable-based soups, energy bars, energy drinks, cracker snacks, olives, herbal teas, and supplements. All items to be consumed per day are individually boxed.

In contrast, the control group will continue with their current diet. All patients will complete dietary diaries to estimate calorie intake during this time period.

Researchers will collect blood, stool, plaque and gingival crevicular fluid samples from each patient at different time points.

Besides, they will call the patients one or two times during each FMD cycle to check that everything is proceeding properly and to solve any problems or concerns they may have. In addition, a trained registered dietitian will be available during the whole study period in case participants need some support or have doubts and/or questions.

If participants miss multiple visits (e.g. 2/3) will be considered as a drop-out and, if they develop a serious medical condition, they might be excluded from the study. However, independently from the participation into this study, each patient will have their gum disease regularly treated.

People with periodontal disease usually have a bad dietary-habits. This investigation with its holistic approach might lead people to modify their unbalanced diet due to the possible related local and systemic benefits. In addition, cycles of 5 days might consistently raise the adherence and willingness to follow such a fasting regime.

详细描述

Introduction

Periodontitis is a microbially-driven inflammatory disease of the periodontium. It has been shown that the periodontitis-associated inflammation is not limited to the periodontium, but may have far-reaching consequences in the rest of the body, and that this may be partly mediated by systemic spread of oral microorganisms. Steps 1 and 2 of periodontal therapy is also associated with a short-term acute phase inflammatory response, characterised by elevation of circulating acute-phase inflammatory markers, which in turn is followed, if successful, by a longer-term reduction in these molecules. In the intermediate to longer term this is accompanied by changes in other markers of peripheral vascular health alongside improvements in metabolic control lasting at least 12 months. Periodontitis is known to have a bidirectional relationship with metabolic disruption and dysregulation. A very recent work corroborated that periodontitis is associated with systemic inflammation as measured by serum C-reactive protein (CRP) levels. Furthermore, it has been reported that intensive non-surgical periodontitis treatment (steps 1 and 2) led to a progressive reduction of CRP after 90 days with a moderate increase at 180 days. It is thought that improvements in metabolic control may also improve periodontal outcomes, yet the exact mechanisms for this are not fully clear. Several human and experimental investigations have also been published concerning the possible effects of nutrition on management of periodontitis. A study on monkeys found that long-term dietary caloric restriction (diet enriched with vitamins and minerals) dampens clinical inflammation and reduces the degree of periodontal breakdown secondary to acute microbial challenge. However, in another experimental study on monkeys, long-term hypocaloric diet (30% less of daily calories intake plus vitamins and minerals) appeared to differentially reduce the production of local inflammatory mediators and the risk for inflammatory periodontal disease among males but not females. In addition, a recent systematic review on animal models concluded that macronutrients that have an effect on oxidative stress or immune system (i.e., n-3 fatty acid) seem to be important for the prevention or treatment of periodontitis. In terms of human research, a Korean group, after a four-week weight control intervention in periodontally healthy obese people, observed a reduction of matrix metalloproteinase (MMP)-8, MMP-9, and interleukin-1β (IL-1β) in gingival crevicular fluid (GCF). A German team reported that a diet consisting of low carbohydrate intake, richness in Omega 3-fatty acids and fibre, higher vitamin C and D values, reduction of animal proteins, and focused intake of nitrate-containing plants might lead to a significant reduction in periodontal and gingival inflammation, even though serological inflammatory parameters and the subgingival microbiome seem to be unaffected. More recently, a study found that there was no overall association between Western dietary patterns (characterized by a higher intake of processed meat, red meat, butter, high-fat dairy products, eggs and refined grains) or prudent dietary patterns (characterized by a higher intake of vegetables, fruit, legumes, whole grains, fish and poultry) and periodontitis; however when solely obese individuals were considered, a Western diet was related to a higher risk of periodontitis. Another very recent investigation, based on use of a dietary inflammatory index, showed that consuming a pro-inflammatory diet was associated with moderate-severe periodontitis in the U.S. general adult population. A novel mode of fasting has been introduced in order to increase patient compliance, due to the fact that people are usually not able to follow a strict diet for a long period. In particular, the fasting mimicking diet (FMD), consisting of 30-50% of the normal caloric intake for 4-7 consecutive days followed by a refeeding ad libitum period once a month, showed very promising beneficious effects in terms of reduction of risk factors for aging, diabetes, autoimmunity, cardiovascular disease, neurodegeneration and cancer. Overall, there is still uncertainty about a potential role of periodic fasting on periodontal clinical and inflammatory parameters. To our knowledge, no studies have investigated the potential effect of FMD on systemic and periodontal response after periodontitis treatment.

Objectives

The main aim of this study is to test if a fasting mimicking diet can influence the systemic and periodontal response following non-surgical periodontal therapy. The null hypothesis is that a fasting mimicking diet does not modify the local and systemic inflammatory post-treatment response.

Study Design

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-70 years
  • Periodontitis stages III-IV, generalized, grade C-B (according to the New World Workshop 2017)
  • Minimum of 20 teeth present: to ensure there are sufficient teeth for study and that the same teeth can be examined in all participants.
  • Systemically healthy participants (self-reported questionnaires will be used).
  • Body mass index: 18.5-30 kg/m2 (normal weight to overweight, but not obese)
  • Be willing and competent (verbally and cognitively) to give written informed consent and complete a medical history form
  • Be willing and physically able to carry out all study procedures (e.g. multiple cycles of a 5-day dietary regimen and blood samples)
  • Absence of hopeless teeth, acute dental conditions, teeth with endodontic-periodontal lesions and necrotising periodontal diseases

排除标准

  • Age > 70 years. Exclusion for safety and feasibility reasons and to minimize the complicating factors such as frailty and un-/under-diagnosed medical conditions.
  • Less than 20 teeth present
  • Patients who received any periodontal treatment in the last 12 months
  • Smoking (defined as self-reported use of any cigarettes or electronic cigarettes for at least 5 years): to avoid the potential confounding effect of smoking
  • Mental illness, including severe depression, dementia. To ensure safety and compliance of the protocol
  • Drug dependency
  • Hormone replacement therapy (DHEA, estrogen, thyroid, testosterone).
  • Severe hypertension (systolic BP > 200 mm Hg and/or diastolic BP > 105 mm Hg)
  • Underweight (BMI < 18.5 kg/m2)
  • Currently taking part in other clinical trials: to prevent either from interfering with the results of the other
  • Pregnant or breastfeeding women: to prevent hormonal changes from influencing the amount of inflammation
  • Taking medications including systemic anti-inflammatory medication within 3 months of the study (NSAIDs, no more than once per week and not in the week before sample collection, is permitted)
  • Systemic antibiotic intake within 3 months: to prevent their microbiome-modulating effects from impacting the inflammatory status.
  • Current orthodontic treatment: interferes with plaque control measures.
  • Alcoholism (alcohol intake greater than two drinks per day for women and three drinks per day for men)
  • Denture wearer/presence of dental implants: They may have an effect on periodontal parameters of neighbouring teeth
  • Obvious signs of untreated caries and other significant oral diseases which in the opinion of the Study Dentist will affect either the scientific validity of the study, or if the volunteer was to participate in the study would affect their wellbeing
  • Unable or unwilling to participate in baseline or follow-up examinations
  • Unable or unwilling to complete the dietary intervention
  • Special dietary requirements incompatible with the study interventions
  • Significant food allergies which would make the subject unable to consume the food provided

研究组 & 干预措施

Control group

No Intervention

Patients will receive the non-surgical periodontal therapy and will continue with their normal (and ad libitum) diet.

Test group

Active Comparator

Patients will receive the non-surgical periodontal therapy plus three cycles of fasting-mimicking diet.

干预措施: Fasting-mimicking diet + non-surgical periodontal therapy (Procedure)

结局指标

主要结局

High-sensitivity C-reactive protein (hs-CRP) values in serum

时间窗: It will be measured at baseline and 90 days after treatment.

Blood samples will be taken. A multiple bead immunoassay technique (Luminex) will be used to detect the serum levels of CRP (as alternative ELISA technique may be used). CRP will be measured in milligrams of the protein per liter of plasma (mg/L).

次要结局

  • Clinical attachment level (CAL)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Probing pocket depth (PPD)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Bleeding on probing (BOP)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Plaque index (PI)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Inflammatory biomarkers from Gingival crevicular fluid (GCF)(GCF will be collected at baseline and 1-, 7-, 45- 90- and 180 days after treatment. Plaque and stool sample will be collected at Baseline and 180 days after treatment)
  • Sub-gingival plaque(Plaque will be collected at Baseline and 180 days after treatment)
  • Stool samples(Stool sample will be collected at Baseline and 180 days after treatment)
  • Patients reported outcome measurements (PROMs)(It will be measured at baseline, and 90- and 180- days after treatment)
  • Hs-CRP values in serum(It will be measured at baseline and 1-, 7-, 45- and 180 days after treatment)
  • Clinical attachment level (CAL)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Probing pocket depth (PPD)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Bleeding on probing (BOP)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Plaque index (PI)(It will be measured at baseline (before treatment) and 90- and 180 days after treatment)
  • Inflammatory biomarkers from Gingival crevicular fluid (GCF)(GCF will be collected at baseline and 1-, 7-, 45- 90- and 180 days after treatment. Plaque and stool sample will be collected at Baseline and 180 days after treatment)
  • Sub-gingival plaque(Plaque will be collected at Baseline and 180 days after treatment)
  • Stool samples(Stool sample will be collected at Baseline and 180 days after treatment)
  • Patients reported outcome measurements (PROMs)(It will be measured at baseline, and 90- and 180- days after treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Fasting-mimicking Diet and Periodontitis (FMD) | 临床试验